Sugentech Inc. develops in-vitro diagnostic systems and products
based on BT-IT-NT convergence technology


Sugentech completed acquisition of K-MAC BioCenter

  • Sep 19, 2018


Sugentech finally completed the acquisition of the K-MAC BioCenter, a subsidary of K-MAC (Korea Materials & Analysis corp). K-MAC BioCenter is specialized in providing high technnology of instrument optimization of in-vitro diagnostics.


This is a significant milestone in our long-term strategy to move forward to become a global leading IVD manufacturer.

The acquisition of K-MAC BioCenter will be the first major step in that journey and we will take a quantum leap toward

securing our competitive position in that space.


Through the M&A, we will do our best to leverage and expand the two companies’ strength, and will also enhance the R&D and improve our performance.